Fredun Pharmaceuticals Ltd — Important, 08-07-2026: Company Update

Fredun Pharmaceuticals received a compliance certificate from its Registrar and Share Transfer Agent, confirming the efficient handling of shareholder records and dematerialisation requests. The certificate verifies that any securities received for dematerialisation during June were processed correctly, with names updated in the register of members. Notably, the report specified that no new shares were dematerialized during that month. This ensures smooth operations for investors holding shares in electronic form and reflects robust compliance with shareholder services.